Frozen microtitration trays manufactured by Micro-Media Systems (MMS) for antimicrobial testing of anaerobic bacteria were evaluated and compared with the broth disk elution method of Virginia Polytechnic Institute (VPI) described by Wilkins and Thiel. A total of 224 clinical anaerobic isolates were tested. Susceptibility results were compared for carbenicillin, cefoxitin, chloramphenicol, clindamycin, penicillin, and tetracycline. Published procedures for the MMS and VPI methods were followed using aerobic inoculation. Growth performance in the MMS method was 74% compared with 89% in the VPI method. For each antibiotic, the MMS minimum inhibitory concentration was compared with the VPI test concentration. Of the 972 drug-organism combinations, 2.9% of the results were discrepant. Clindamycin and tetracycline accounted for 82% of the discrepancies. The MMS anaerobe susceptibility panels were easy to inoculate and interpret and compared well with the VPI broth disk susceptibility method.
Many laboratories rely on the broth disk elution technique (4, 11, 15) for antimicrobial testing of anaerobic bacteria. However, the broth disk method is limited since results are reported qualitatively (susceptible, intermediate, resistant). The awareness and interest in the quantitative measurement of antimicrobial susceptibilities are increasing (1, 10, 16) . In the past, those laboratories interested in applying minimum inhibitory concentrations (MICs) to anaerobes were required to prepare their own microtitration trays and macrotube dilutions or perform the agar gel dilution method (13, 14) . In busy clinical laboratories there is often neither the personnel, time, nor space to prepare or perform such methods. A frozen MIC microtitration tray for anaerobe susceptibility testing is presently available from Micro-Media Systems (MMS), Potomac, Md. The MMS MIC anaerobe panels have yielded results comparable to the agar gel dilution reference method and have shown good intra-and interlaboratory reproducibility (7) . Thus, we evaluated the MMS MIC method by comparing it with the broth disk elution technique of Virginia Polytechnic Institute (VPI) described by Wilkins and Thiel (15) The occurrence of discrepant drug-organism combinations was 2.9% (28 of 972) ( Table 3 ). The most common and consistent discrepancy was the clindamycin-Clostridium combination which accounted for 46% (13 of 28) of all discrepant results. In all instances the MMS MIC value was <1 p,g/ml, with a VPI result of >1. 6 ,ug/ml. Tetracycline accounted for 36% (10 of 28) of the total discrepant results. The discrepancies were variable and occurred with a variety of organisms. Cefoxitin and carbenicillin produced the remaining discrepancies of 10% (3 of 28) and 7% (2 of 28), respectively. Both strains producing the discrepant carbenicillin results were nonviable for CDC evaluation. One isolate which produced a cefoxitin discrepancy was sent to CDC for evaluation. The CDC MIC agreed with the MMS result. Chloramphenicol and penicillin showed no discrepant results. DISCUSSION With the MMS MIC method, the growth performance of the anaerobe isolates was notably less than the growth performance with the VPI method. The slower-growing and more fastidious anaerobes showed the greatest difference, as collectively 62% of the Bacteroides species (non-B. fragilis group isolates), Clostridium species (non-C. perfringens isolates), and anaerobic cocci failed to grow in the MMS MIC method, compared with 23% which failed to grow in the VPI method. In contrast, the faster growing anaerobe isolates, the B. fragilis group and C. perfringens strains, all grew sufficiently for MIC interpretation. Several factors may be responsible. First, the inoculum size used in the VPI method is approximately one log higher (107 CFU) when compared with the MMS MIC inoculum size (106 CFU). The higher inoculum size for the VPI method was originally chosen for better anaerobe growth performance (15) . Second, the broth media used in the two methods are different. Supplemented brain heart infusion medium was used in the VPI method, and Wilkins-Chalgren medium was used in the MMS microtitration trays. Third, a problem of dilution may have contributed to the insufficient growth in the MMS method. The turbidity in the thioglycolate inoculum broth appeared to be similar for the B. fragilis group strains and the clostridial isolates. However, after the inoculum was diluted according to MMS instructions, the final CFU taken from the microtitration plate was much less for the Clostridium isolates when compared with those obtained from the B. fragilis group strains. Further studies are needed to resolve these difficulties.
Of the 13 clostridial isolates showing clindamycin VPI MIC results of >1.6 ,ug/ml and MMS MICs of <1 ,ug/ml, 10 were C. perfringens strains. A clindamycin MIC result of >1.6 ,ug/ml for C. perfringens has seldom been reported. In contrast to the clostridial results, six B. fragilis group strains giving VPI results of >1.6 ,ug/ml for clindamycin had MMS MIC values of >16 jig/ml. We question the VPI clindamycin results for C. perfringens and believe several factors may have contributed to these values. First, the recommended concentrations used in the VPI broth disk method for all antibiotics except clindamycin equal the attainable serum levels of each antibiotic. To reach the clindamycin serum level a large number of disks are needed, which could result in oxidation and possible falsesusceptible results. Thus, the recommended VPI VOL. 17, 1983 on October 26, 2017 by guest http://jcm.asm.org/ Downloaded from test concentration for clindamycin was cut in half (6) . Second, the VPI inoculum size is higher when compared with other anaerobe susceptibility methods (4, 11) . Last, C. perfringens is a rapidly growing anaerobe. These factors could account for the unusually high clindamycin values obtained for C. perfringens with the VPI method. MIC levels performed by CDC on two representative strains of C. perfringens further support the possibility of a methodological problem. The CDC MIC values for clindamycin were 0.5 and -0.01 ,ug/ml for the two strains.
Tetracycline, the second most common discrepant antibiotic, showed a number of different discrepancies occurring with a variety of organisms. Due to the variability of the tetracycline results in anaerobe susceptibility systems (7, 8, 9) and its questionable usefulness in anaerobic infections (5, 12), we question the need for this drug on the anaerobe MMS MIC panel. Doxycycline, a tetracycline derivative, has been shown to have a good spectrum of activity and appears to be effective against the B. fragilis group organisms (2) . This drug would seem to be a reasonable alternative.
A purity plate, as outlined in Materials and Methods, is recommended as a check for insufficient growth in addition to the check for purity. When tested by CDC, a Clostridium ramosum isolate gave a three-to seven-well MIC increase for three of the antibiotics tested when compared with the MMS results. Growth in the MMS panel was present only in the control well, indicating a very susceptible organism. However, the corresponding purity plate had only three colonies present, suggesting insufficient growth of the isolate. Thus, the purity plate should be examined for sufficient growth to prevent the reporting of erroneous susceptible results.
We found that the MMS anaerobe panels were easy to inoculate and interpret. No additional time, personnel, or space was necessary for preparation, inoculation, and interpretation of the MIC panels when compared with the VPI broth disk method. The MMS MIC endpoints were clear and well defined for the antibiotics and organisms used in this study. In conclusion, the MMS anaerobe panel compared well with the broth disk method for routine clinical use.
